I received the below letter from Dr. Stanislaw Burzynski regarding the omissions from the Dateline story, which aired this past Sunday night. Dr. Burzynski is a serious scientist and I believe will one day be regarded as the Jonas Salk of our times.
I am reminded of the Arthur Schopenhauer quote on the three stages of truth. "Every truth passes through three stages before it is recognized. In the first it is ridiculed, in second it is opposed, in the third it is regarded as self-evident." Regarding the truth about cancer and alternatives, we are deep into “violent opposition.”
Please read Dr. Burzynski's letter in response to his appearance on Dateline. As you will clearly see, he was misrepresented there was no mention that he has completed Phase II clinical trials in compliance with the FDA! Knowing this would have been very convincing to the viewing audience but, unfortunately, it was omitted. I personally have seen, and/or spoken with many, many of Dr. Burzynski's “cured” patients. Sadly, their stories were also omitted. Many of these patients are written about in KNOCKOUT.
If ever you or a loved one are in the terrible situation of being diagnosed you will be grateful there are doctors like Dr. Burzynski and Dr. Gonzalez who offer other options.
Dateline is known to expose criminals, and they are good at this. There is no doubt that for them to produce the story at all, which we saw on Sunday, is our success. The interviews with you and the patients were great, and with Dr. Gonzalez and me, not too bad. The photographic part was also very good. What was absent was investigative acumen of the two women regarding the experts presented, who are simply crooks. Their lies and half-truths should be exposed. First of all, there was no doctor on the show who knows anything about the treatment of brain tumors. One of the experts was not an oncologist and not even a medical doctor, (the woman from Sloane Kettering, Barrie Casselith is a PhD, Chief Integrative Medicine Service), and the other doctor has nothing to do with the treatment of patients. The third “expert” recently changed places from M.D. Anderson to Cancer Treatment Centers of America, and certainly, he has never treated brain tumors in his life. Dateline was reluctant to give the credentials of these experts, yet, on the other hand, they refused to present our sources, who actually work in the field.
I repeatedly mentioned Dr. Julian Whitaker to them as an excellent expert, and who would have been much better than Dr. Andrew Weil, an M.D. who has no expertise in cancer or oncology. Because Dateline did not include the experts who were on our side, I felt the story was poorly balanced. The doctors featured knew very well that we have numerous successful Phase II clinical trials, which show statistics of patient responses; therefore, these are not "anecdotal case reports", as he said. The producers of Dateline are also aware that we are now in Phase III clinical trials, which clearly proves that the treatment is safe and efficacious. At the beginning of last year we made a public announcement about Phase III clinical trials conducted in Japan, which compares the results of antineoplastons with standard chemotherapy in colon cancer (killing the argument of the doctor from M.D. Anderson that the treatment was not compared with standard therapy). When he looked at our publications he purposely picked up the abstract from the Congress of Neuro-Oncology as proof that we have only published abstracts, and not full-length, peer-reviewed papers. He knew very well that the stack of the papers, which he had in front of him, consisted of peer-reviewed papers as well as book chapters. At that same time, the Dateline reporter (Dr. Nancy Snyderman) knew very well what was going on, yet did not expose it as a pack of lies and half-truths. This goes poorly with such refined investigative reporting. My belief is that the "experts" were working on behalf of the American Cancer Society to desperately cover the truth and defend their losing ground.
Dateline raised the issue of "transparency of our records." During their visits to our clinic they had unlimited access to patients whom they interviewed, and their medical records and scans. After they left, they requested that we send all of our films of the scans of successfully treated brain tumor patients to them so that their experts could review them. We informed Dateline that according to the rules governing clinical trials, we have to keep the originals in well-organized archives. They could not be sent to Dateline for review, but we would be glad to make them available for their experts if they wanted to visit our clinic. One of our radiologists would accompany them, and we would assign a special office for them. We told them they could stay as long as they wished. We were surprised to hear that the experts refused to do it, because they were too busy. Subsequently, Dateline requested that we make copies of the x-rays to send to them. We immediately contacted an imaging center, which promised to do it within approximately six weeks, for $14,000 (we are talking about hundreds of x-rays which needed to be either copied or converted to CDs). The time and the amount of money to proceed with this project were unacceptable to Dateline. They narrowed down their request to a smaller number of x-rays, but still the amount of money necessary to do it was in the range of $2,000. Subsequently, the project was dropped by Datelin
Anyway, smart people will know very well what is going on. Congratulations to you. I have no doubt that the next story will be much better.
Stanislaw R. Burzynski, M.D., PhD.
9432 Katy Freeway, #200
Houston, TX 77055